|
[1]
|
Singer, M., Deutschman, C.S., Seymour, C.W., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Brown, R.M., Wang, L., Coston, T.D., et al. (2019) Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial. American Journal of Respiratory and Critical Care Medicine, 200, 1487-1495. [Google Scholar] [CrossRef]
|
|
[3]
|
Sankar, J., Muralidharan, J., Lalitha, A.V., et al. (2023) Multiple Electrolytes Solution versus Saline as Bolus Fluid for Resuscitation in Pediatric Septic Shock: A Multicenter Randomized Clinical Trial. Critical Care Medicine, 51, 1449-1460. https://pubmed.ncbi.nlm.nih.gov/37294145/ [Google Scholar] [CrossRef]
|
|
[4]
|
Corl, K.A., Prodromou, M., Merchant, R.C., et al. (2019) The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study. Critical Care Medicine, 47, 951-959. [Google Scholar] [CrossRef]
|
|
[5]
|
Meyhoff, T.S., Hjortrup, P.B., Wetterslev, J., et al. (2022) Restriction of Intravenous Fluid in ICU Patients with Septic Shock. New England Journal of Medicine, 386, 2459-2470.
|
|
[6]
|
Moreau, R., Hadengue, A., Soupison, T., et al. (1992) Septic Shock in Patients with Cirrhosis: Hemodynamic and Metabolic Characteristics and Intensive Care Unit Outcome. Critical Care Medicine, 20, 746-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Olson, J.C., Wendon, J.A., Kramer, D.J., et al. (2011) Intensive Care of the Patient with Cirrhosis. Hepatology, 54, 1864-1872. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Philips, C.A., Maiwall, R., Sharma, M.K., et al. (2021) Comparison of 5% Human Albumin and Normal Saline for Fluid Resuscitation in Sepsis Induced Hypotension among Patients with Cirrhosis (FRISC Study): A Randomized Controlled Trial. Hepatology International, 15, 983-994. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Maiwall, R., Kumar, A., Pasupuleti, S.S.R., et al. (2022) A Randomized-Controlled Trial Comparing 20% Albumin to Plasmalyte in Patients with Cirrhosis and Sepsis-Induced Hypotension [ALPS Trial]. Journal of Hepatology, 77, 670-682. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Rochwerg, B., Alhazzani, W., Sindi, A., et al. (2014) Fluid Resuscitation in Sepsis: A Systematic Review and Network Meta-Analysis. Annals of Internal Medicine, 161, 347-355. [Google Scholar] [CrossRef]
|
|
[11]
|
Monnet, X., Lai, C., Ospina-Tascon, G., et al. (2023) Evidence for a Personalized Early Start of Norepinephrine in Septic Shock. Critical Care, 27, Article No. 322. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Permpikul, C., Tongyoo, S., Viarasilpa, T., et al. (2019) Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial. American Journal of Respiratory and Critical Care Medicine, 199, 1097-1105. [Google Scholar] [CrossRef]
|
|
[13]
|
Zhou, W.-J., Cui, J.-K., Liu, M., et al. (2021) Comparison of Norepinephrine, Dopamine and Dobutamine Combined with Enteral Nutrition in the Treatment of Elderly Patients Harboring Sepsis. Pakistan Journal of Pharmaceutical Sciences, 34, 957-961.
|
|
[14]
|
He, Y., Chen, X., Zhang, G., et al. (2022) Clinical Efficacy and Safety of Norepinephrine Combined with Ulinastatin in the Treatment of Septic Shock. Pakistan Journal of Pharmaceutical Sciences, 35, 657-663.
|
|
[15]
|
Wang, J., Shi, M., Huang, L., et al. (2022) Addition of Terlipressin to Norepinephrine in Septic Shock and Effect of Renal Perfusion: A Pilot Study. Renal Failure, 44, 1208-1216. [Google Scholar] [CrossRef]
|
|
[16]
|
Senatore, F., Jagadeesh, G., Rose, M., et al. (2019) FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock. American Journal of Cardiovascular Drugs, 19, 11-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ibarra-Estrada, M., Kattan, E., Aguilera-González, P., et al. (2023) Early Adjunctive Methylene Blue in Patients with Septic Shock: A Randomized Controlled Trial. Critical Care, 27, Article No. 110. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ismail, R., Awad, H., Allam, R., et al. (2022) Methylene Blue versus Vasopressin Analog for Refractory Septic Shock in the Preterm Neonate: A Randomized Controlled Trial. Journal of Neonatal-Perinatal Medicine, 15, 265-273. [Google Scholar] [CrossRef]
|
|
[19]
|
Adly, D.H.E., Bazan, N.S., El Borolossy, R.M., et al. (2022) Midodrine Improves Clinical and Economic Outcomes in Patients with Septic Shock: A Randomized Controlled Clinical Trial. Irish Journal of Medical Science, 191, 2785-2795. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Davoudi-Monfared, E., Mohammadi, M., Khoshavi, M., et al. (2021) The Effect of Midodrine on Lactate Clearance in Patients with Septic Shock: A Pilot Study. Journal of Comparative Effectiveness Research, 10, 673-683. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Mirjalili, M., Zand, F., Karimzadeh, I., et al. (2023) The Clinical and Paraclinical Effectiveness of Four-Hour Infusion vs. Half-Hour Infusion of High-Dose Ampicillin-Sulbactam in Treatment of Critically Ill Patients with Sepsis or Septic Shock: An Assessor-Blinded Randomized Clinical Trial. Journal of Critical Care, 73, Article 154170. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Liu, S., Wu, Y., Qi, S., et al. (2023) Polymyxin B Therapy Based on Therapeutic Drug Monitoring in Carbapenem-Resistant Organisms Sepsis: The PMB-CROS Randomized Clinical Trial. Critical Care, 27, Article No. 232. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Roggeveen, L.F., Guo, T., Fleuren, L.M., et al. (2022) Right Dose, Right Now: Bedside, Real-Time, Data-Driven, and Personalised Antibiotic Dosing in Critically Ill Patients with Sepsis or Septic Shock—A Two-Centre Randomised Clinical Trial. Critical Care, 26, Article No. 265. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Balik, M., Maly, M., Brozek, T., et al. (2023) Propafenone versus Amiodarone for Supraventricular Arrhythmias in Septic Shock: A Randomised Controlled Trial. Intensive Care Medicine, 49, 1283-1292. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Liu, H., Ding, X.F., Zhang, S.G., et al. (2019) [Effect of Esmolol in Septic Shock Patients with Tachycardia: A Randomized Clinical Trial]. National Medical Journal of China, 99, 1317-1322.
|
|
[26]
|
Wang, J., Gao, X., He, Z., et al. (2023) Evaluating the Effects of Esmolol on Cardiac Function in Patients with Septic Cardiomyopathy by Speck-Tracking Echocardiography—A Randomized Controlled Trial. BMC Anesthesiology, 23, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Cocchi, M.N., Dargin, J., Chase, M., et al. (2022) Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial. Shock, 57, 508-517. [Google Scholar] [CrossRef]
|
|
[28]
|
Kakihana, Y., Nishida, O., Taniguchi, T., et al. (2020) Efficacy and Safety of Landiolol, an Ultra-Short-Acting β1-Selective Antagonist, for Treatment of Sepsis-Related Tachyarrhythmia (J-Land 3S): A Multicentre, Open-Label, Randomised Controlled Trial. The Lancet Respiratory Medicine, 8, 863-872. [Google Scholar] [CrossRef]
|
|
[29]
|
Datta, P.K., Rewari, V., Ramachandran, R., et al. (2021) Effectiveness of Enteral Ivabradine for Heart Rate Control in Septic Shock: A Randomised Controlled Trial. Anaesthesia and Intensive Care, 49, 366-378. [Google Scholar] [CrossRef]
|
|
[30]
|
Iglesias, J., Vassallo, A.V., Patel, V.V., et al. (2020) Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis: The ORANGES Trial. Chest, 158, 164-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Hussein, A.A., Sabry, N.A., Abdalla, M.S., et al. (2021) A Prospective, Randomised Clinical Study Comparing Triple Therapy Regimen to Hydrocortisone Monotherapy in Reducing Mortality in Septic Shock Patients. International Journal of Clinical Practice, 75, e14376. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Lyu, Q.-Q., Zheng, R.-Q., Chen, Q.-H., et al. (2022) Early Administration of Hydrocortisone, Vitamin C, and Thiamine in Adult Patients with Septic Shock: A Randomized Controlled Clinical Trial. Critical Care, 26, Article No. 295. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Wani, S.J., Mufti, S.A., Jan, R.A., et al. (2020) Combination of Vitamin C, Thiamine and Hydrocortisone Added to Standard Treatment in the Management of Sepsis: Results from an Open Label Randomised Controlled Clinical Trial and a Review of the Literature. Infectious Diseases, 52, 271-278. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Tilouche, N., Jaoued, O., Ali, H.B.S., et al. (2019) Comparison between Continuous and Intermittent Administration of Hydrocortisone during Septic Shock: A Randomized Controlled Clinical Trial. Shock, 52, 481-486. [Google Scholar] [CrossRef]
|
|
[35]
|
Venkatesh, B., Finfer, S., Cohen, J., et al. (2019) Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: A Post Hoc Analysis of the ADRENAL Trial. Anesthesiology, 131, 1292-1300. [Google Scholar] [CrossRef]
|
|
[36]
|
Ortiz-Reyes, L., Patel, J.J., Jiang, X., et al. (2022) Early versus Delayed Enteral Nutrition in Mechanically Ventilated Patients with Circulatory Shock: A Nested Cohort Analysis of an International Multicenter, Pragmatic Clinical Trial. Critical Care, 26, Article No. 173. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
El-Nawawy, A.A., Elshinawy, M.I., Khater, D.M., et al. (2021) Outcome of Early Hemostatic Intervention in Children with Sepsis and Nonovert Disseminated Intravascular Coagulation Admitted to PICU: A Randomized Controlled Trial. Pediatric Critical Care Medicine, 22, e168-e177. [Google Scholar] [CrossRef]
|
|
[38]
|
Yoshihiro, S., Sakuraya, M., Hayakawa, M., et al. (2019) Recombinant Human-Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients with Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset. Shock, 51, 174-179. [Google Scholar] [CrossRef]
|
|
[39]
|
Sun, T., Zhang, N., Cui, N., et al. (2023) Efficacy of Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy. Journal of Cardiothoracic and Vascular Anesthesia, 37, 344-349. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
He, J., Zhao, X., Lin, X., et al. (2021) The Effect of Xinmailong Infusion on Sepsis-Induced Myocardial Dysfunction: A Pragmatic Randomized Controlled Trial. Shock, 55, 33-40. [Google Scholar] [CrossRef]
|
|
[41]
|
Sun, R., Liang, M., Yang, H., et al. (2020) [Effect of Xuebijing on Inflammatory Response and Prognosis in Patients with Septic Shock]. Chinese Critical Care Medicine, 32, 458-462.
|
|
[42]
|
Mai, Z., Tan, Y., Zhu, Y., et al. (2023) Effects of Low-Dose Furosemide Combined with Aminophylline on the Renal Function in Septic Shock Patients. Renal Failure, 45, Article 2185084. [Google Scholar] [CrossRef]
|
|
[43]
|
Zhang, F., Mei, X., Zhou, P., et al. (2023) Anisodamine Hydrobromide in the Treatment of Critically Ill Patients with Septic Shock: A Multicenter Randomized Controlled Trial. Annals of Medicine, 55, Article 2264318. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Guo, M. and Zhou, B. (2023) Clinical Efficacy of Ulinastatin in the Treatment of Unliquefied Pyogenic Liver Abscess Complicated by Septic Shock: A Randomized Controlled Trial. Immunity, Inflammation and Disease, 11, e822. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Aisa-Alvarez, A., Soto, M.E., Guarner-Lans, V., et al. (2020) Usefulness of Antioxidants as Adjuvant Therapy for Septic Shock: A Randomized Clinical Trial. Medicina, 56, Article 619. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Xie, Y.-J., Mo, W.-G., Wei, Y., et al. (2020) [Effect of Early Continuous Blood Purification on the Prognosis of Children with Septic Shock: A Prospective Randomized Controlled Clinical Trial]. Chinese Journal of Contemporary Pediatrics, 22, 573-577.
|
|
[47]
|
Zhang, Y., Shao, D.R., He, Z.P., et al. (2019) Efficacy of Continuous Renal Replacement on Acute Renal Injury Developed in Severe Sepsis. Journal of Biological Regulators and Homeostatic Agents, 33, 525-530.
|
|
[48]
|
Schwindenhammer, V., Girardot, T., Chaulier, K., et al. (2019) oXiris® Use in Septic Shock: Experience of Two French Centres. Blood Purification, 47, 29-35. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Feng, J., Zhang, S., Ai, T., et al. (2022) Effect of CRRT with oXiris Filter on Hemodynamic Instability in Surgical Septic Shock with AKI: A Pilot Randomized Controlled Trial. The International Journal of Artificial Organs, 45, 801-808. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ferrari, F., Husain-Syed, F., Milla, P., et al. (2022) Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock. Blood Purification, 51, 912-922. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Bai, L., Qiu, X., Ding, X., et al. (2022) Value of Thymosin α1 Combined with Blood Purification to Increase Successful Rescues of Shock Patients. Alternative Therapies in Health and Medicine, 28, 146-152.
|
|
[52]
|
Rey, S., Kulabukhov, V.M., Popov, A., et al. (2023) Hemoperfusion Using the LPS-Selective Mesoporous Polymeric Adsorbent in Septic Shock: A Multicenter Randomized Clinical Trial. Shock, 59, 846-854. [Google Scholar] [CrossRef]
|
|
[53]
|
Lu, X., Zhai, H., Dong, Y., et al. (2022) Therapeutic Effect and Prognosis of PiCCO in the Treatment of Myocardial Injury Complicated with Septic Shock. Computational and Mathematical Methods in Medicine, 2022, Article ID: 2910849. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Yao, Y., Su, M., Guan, Y., et al. (2021) Clinical Application of Transabdominal Ultrasound Combined with PiCCO in Septic Shock Fluid Resuscitation and Its Predictive Value for Survival Outcome. Ultrasound in Medicine & Biology, 47, 3196-3201. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Zhou, X., Zhang, Y., Pan, J., et al. (2022) Optimizing Left Ventricular-Arterial Coupling during the Initial Resuscitation in Septic Shock—A Pilot Prospective Randomized Study. BMC Anesthesiology, 22, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Wang, S., Zhu, J., Zhao, Z.-G., et al. (2020) [Effect of Early Acupoint Electrical Stimulation on Lower Limb Muscle Strength in Patients with Septic Shock]. Chinese Acupuncture & Moxibustion, 40, 1173-1177.
|
|
[57]
|
Khalil, M.T. and Rathore, F.A. (2022) Neuromuscular Electrical Stimulator as a Protective Treatment against Intensive Care Unit Muscle Wasting in Sepsis/Septic Shock Patients. Journal of the College of Physicians and Surgeons Pakistan, 32, 1300-1307. [Google Scholar] [CrossRef] [PubMed]
|